About BTAA
Brain Tumour Alliance Australia (BTAA) is the national brain tumour patient and carer support organisation in Australia. It was established in late 2008 by a group of brain tumour patients, and current and former carers. While welcoming the advice and input of specialists, BTAA seeks to represent the brain tumour community from the viewpoint of the patient, their carers, and their families.
Brain Cancer Information
Understanding brain cancer can feel overwhelming, especially at the beginning. This section provides clear, reliable information covering types of brain tumours, grading, diagnosis, treatment pathways, and what it means to live with the condition—along with key facts and insights to help you feel more informed and prepared.
Support and Resources
Support looks different for everyone, and BTAA is here to help you find what you need. Through our peer support helpline, educational patient forums, and connections to trusted support groups and organisations, we offer pathways to information, understanding and community.
Advocacy & Awareness
BTAA connects people, organisations, and government to foster collaboration and build awareness. We educate the community and inform decision-makers to shape policy and better outcomes.
Get Involved
There are many meaningful ways to get involved with BTAA. Whether you choose to make a donation, volunteer your time, become a member, share your story, or support our awareness efforts, every contribution helps strengthen our community and drive impact for those affected by brain tumours.
Latest News
Stay up to date with the latest news, events and stories from the brain tumour community. This section features updates from BTAA, highlights of past and upcoming events, access to BTAA and IBTA magazines, and personal stories that share experiences, insights and inspiration from those affected.
Head to the Hill 2026
Head to the Hill 2026 will be held on Wednesday, 14 October 2026 in the Great Hall at Parliament House in Canberra.
This national advocacy event brings together patients, carers, families, clinicians, researchers and supporters from across Australia to share their stories and call for urgent action on brain cancer — the deadliest cancer for children and young adults.
LATEST NEWS
Voranigo Listed on the PBS: A Landmark Step Forward for Australians with IDH-Mutant Brain Tumours
Australians living with IDH-mutant astrocytoma and oligodendroglioma now have subsidised access to Voranigo (vorasidenib), following its listing on the Pharmaceutical Benefits Scheme (PBS) from 1 August 2026. The Australian Government has described Voranigo as the first new treatment in 20 years for these rare brain cancers – marking an important and long-awaited development for patients and families who have faced limited treatment options.
A temporary pause of the BTAA Helpline Support Service
The BTAA Helpline service to callers requesting support for brain tumours and related neurological issues will be temporarily paused for a period of review and reassessment. While we are unable to take your call during this period, we wish to redirect your concerns or questions to a dedicated and appropriately resourced agency able to provide advice and support for your situation.
Vale Professor Richard Scolyer AO
BTAA shares this statement on behalf of BTAA and the Australian Brain Tumour Collaborative (ABTC). Today, on World Brain Tumour Awareness Day, we honour the life and legacy of Professor Richard Scolyer AO — a giant of Australian science, a courageous patient, and an enduring champion for the brain cancer community.
EVENTS
PERSONAL STORIES
We gratefully acknowledge Telix Pharmaceuticals for their support of our website redevelopment.



